146 related articles for article (PubMed ID: 2898636)
21. Discontinuous transdermal nitroglycerin as treatment for stable angina in the elderly: a double-blind multicentre study. The Transdermal TNG Trial Group of Istituto Nazionale Ricovero e Cura Anziani (I.N.R.C.A.).
Paciaroni E; Luca C
Eur Heart J; 1991 Oct; 12(10):1076-80. PubMed ID: 1782932
[TBL] [Abstract][Full Text] [Related]
22. Use of transdermal glyceryl trinitrate to reduce failure of intravenous infusion due to phlebitis and extravasation.
Wright A; Hecker JF; Lewis GB
Lancet; 1985 Nov; 2(8465):1148-50. PubMed ID: 2865615
[TBL] [Abstract][Full Text] [Related]
23. Comparative clinical trial of the tolerability, patient acceptability and efficacy of two transdermal glyceryl trinitrate patches ('Deponit' 5 and 'Transiderm-Nitro' 5) in patients with angina pectoris.
Vallé-Jones C; O'Hara J; O'Hara H
Curr Med Res Opin; 1989; 11(5):331-9. PubMed ID: 2495215
[TBL] [Abstract][Full Text] [Related]
24. Antianginal efficacy of a new nitroglycerin patch.
Parker JO
Eur Heart J; 1989 May; 10 Suppl A():43-9. PubMed ID: 2501094
[TBL] [Abstract][Full Text] [Related]
25. A double-blind multiple crossover trial evaluating a transdermal nitroglycerin system vs placebo.
Dickstein K; Knutsen H
Eur Heart J; 1985 Jan; 6(1):50-6. PubMed ID: 3924617
[TBL] [Abstract][Full Text] [Related]
26. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
Kapoor AS; Dang NS; Reynolds RD
Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
[TBL] [Abstract][Full Text] [Related]
27. Randomised, double-blind, placebo-controlled clinical trial of a new topical glyceryl trinitrate patch for chronic lateral epicondylosis.
Paoloni JA; Murrell GA; Burch RM; Ang RY
Br J Sports Med; 2009 Apr; 43(4):299-302. PubMed ID: 18971247
[TBL] [Abstract][Full Text] [Related]
28. Effect of pre-treatment with transdermal glyceryl trinitrate on myocardial ischaemia during coronary angioplasty.
Ramamurthy S; Mehan V; Kaufmann U; Verin V; Lüscher TF; Meier B
Heart; 1996 Dec; 76(6):471-6. PubMed ID: 9014793
[TBL] [Abstract][Full Text] [Related]
29. Intermittent Administration of Nitroglycerin Sublingual Powder Compared with Placebo in Outpatients with Peripheral Artery Disease: Results of a Randomised Proof of Concept Study.
Lawall H; Bramlage P; Gorath M; Wittig T
Eur J Vasc Endovasc Surg; 2021 Mar; 61(3):457-465. PubMed ID: 33358350
[TBL] [Abstract][Full Text] [Related]
30. [PLacebo-controlled double blind study of the anti-ischemic efficacy of transdermal depot nitrate].
Reifart N; Bussmann WD
Z Kardiol; 1986; 75 Suppl 3():83-5. PubMed ID: 3099487
[TBL] [Abstract][Full Text] [Related]
31. Transdermal nitroglycerin (Transiderm-Nitro) in the treatment of unstable angina pectoris.
Dahlstrøm CG; Rasmussen K; Bagger JP; Henningsen P; Haghfelt T
Dan Med Bull; 1986 Oct; 33(5):265-7. PubMed ID: 3096643
[TBL] [Abstract][Full Text] [Related]
32. Anti-anginal therapy and quality of life. A comparison of the effects of transdermal nitroglycerin and long-acting oral nitrates.
Nissinen A; Wiklund I; Lahti T; Akkila J; Wilson A; Wahl M; Puska P
J Clin Epidemiol; 1991; 44(9):989-97. PubMed ID: 1909749
[TBL] [Abstract][Full Text] [Related]
33. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment in patients with chronic anal fissures.
Scholefield JH; Bock JU; Marla B; Richter HJ; Athanasiadis S; Pröls M; Herold A
Gut; 2003 Feb; 52(2):264-9. PubMed ID: 12524411
[TBL] [Abstract][Full Text] [Related]
34. Transdermal glyceryl trinitrate patches (Transiderm-Nitro).
Drug Ther Bull; 1986 Jan; 24(2):5-6. PubMed ID: 3086066
[No Abstract] [Full Text] [Related]
35. Transdermal nitroglycerin: clinical and pharmacokinetic consequences of renewing the patch and the application site.
Klemsdal TO; Mundal HH; Bredesen JE; Gjesdal K
Eur J Clin Pharmacol; 1997; 52(5):379-81. PubMed ID: 9272407
[TBL] [Abstract][Full Text] [Related]
36. Double-blind trial of nifedipine in angina patients with normal coronary arteries.
Pitcher D; Sowton E
Pharmatherapeutica; 1981; 3(1):6-13. PubMed ID: 6798584
[TBL] [Abstract][Full Text] [Related]
37. Chronic effects of transdermal nitroglycerin in stable angina pectoris: a within-patient, placebo-controlled study.
Gibelli G; Negrini M; Bruno AM; Fiorini GL; Lambiase M; Magenta G; Corti D; Prina L; Pollavini PG; De Ponti C
Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):436-41. PubMed ID: 2509380
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II-receptor antagonist losartan does not prevent nitroglycerin tolerance in patients with coronary artery disease.
Longobardi G; Ferrara N; Leosco D; Abete P; Furgi G; Cacciatore F; Corbi G; Pescatore R; Rengo F
Cardiovasc Drugs Ther; 2004 Sep; 18(5):363-70. PubMed ID: 15717138
[TBL] [Abstract][Full Text] [Related]
39. Studies on the response of nitroglycerin oral spray compared with sublingual tablets for angina pectoris patients with dry mouth. A multicenter trial.
Sato H; Koretsune Y; Taniguchi T; Fukui S; Shimazu T; Sugii M; Matsuyama T; Karita M; Hori M
Arzneimittelforschung; 1997 Feb; 47(2):128-31. PubMed ID: 9079231
[TBL] [Abstract][Full Text] [Related]
40. Perianal versus endoanal application of glyceryl trinitrate 0.4% ointment in the treatment of chronic anal fissure: results of a randomized controlled trial. Is this the solution to the headaches?
Pérez-Legaz J; Arroyo A; Moya P; Ruiz-Tovar J; Frangi A; Candela F; Oliver MI; Calpena R
Dis Colon Rectum; 2012 Aug; 55(8):893-9. PubMed ID: 22810476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
